In contrast to other clinically used microtubule inhibitors, MPT0B098 is effective in suppressing tumor growth despite p-gp170/MDR status [11], and can destabilize HIF-1α mRNA under hypoxic conditions by inhibiting the translocation of human antigen R (HuR) from the nucleus to the cytoplasm [12]. Here, HIF1A is linked to neoplasm.